Overview

A Multi-Center Trial of Nepicastat for Cocaine Dependence

Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the safety and efficacy of Nepicastat in improving the number of subjects that achieve abstinence from cocaine and reducing cocaine use in subjects with cocaine dependence.
Phase:
Phase 2
Details
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Treatments:
Cocaine
Riboflavin